Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (171-180 of 457) with videos related to

Pageof 46
Sort By:
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center ExperienceMoussab Damlaj, Nanna H Sulai, Jennifer L Oliveira, et al.
Leukemia & Lymphoma|April 28, 2025
Feasibility and safety of outpatient hypomethylating agent and venetoclax initiation with and without ramp-up for newly diagnosed acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Rory M Shallis, Julian J Weiss, Eric S Winer, et al.
Haematologica|March 2, 2023
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapyNaseema Gangat, Rimal Ilyas, Isla M Johnson, et al.
American Journal of Clinical Pathology|April 29, 2016
Is It Time for a New Gold Standard? FISH vs Cytogenetics in AML DiagnosisRichard D Hammer, Donald Doll, Lester Layfield, et al.
Blood|January 10, 2002
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitroBenjamin M F Mow, Joya Chandra, Phyllis A Svingen, et al.
Science Signaling|February 10, 2026
Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemiaJaewoong Lee, Ruifeng Sun, Kohei Kume, et al.
Blood Advances|October 1, 2021
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trialsChezi Ganzel, Ju-Whei Lee, Hugo F Fernandez, et al.
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
European Journal of Haematology|October 26, 2011
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapyMichelle A Elliott, Louis Letendre, Ayalew Tefferi, et al.
Pageof 46

Showing results (171-180 of 457) with videos related to

Sort By:
Pageof 46
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center ExperienceMoussab Damlaj, Nanna H Sulai, Jennifer L Oliveira, et al.
Leukemia & Lymphoma|April 28, 2025
Feasibility and safety of outpatient hypomethylating agent and venetoclax initiation with and without ramp-up for newly diagnosed acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Rory M Shallis, Julian J Weiss, Eric S Winer, et al.
Haematologica|March 2, 2023
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapyNaseema Gangat, Rimal Ilyas, Isla M Johnson, et al.
American Journal of Clinical Pathology|April 29, 2016
Is It Time for a New Gold Standard? FISH vs Cytogenetics in AML DiagnosisRichard D Hammer, Donald Doll, Lester Layfield, et al.
Blood|January 10, 2002
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitroBenjamin M F Mow, Joya Chandra, Phyllis A Svingen, et al.
Science Signaling|February 10, 2026
Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemiaJaewoong Lee, Ruifeng Sun, Kohei Kume, et al.
Blood Advances|October 1, 2021
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trialsChezi Ganzel, Ju-Whei Lee, Hugo F Fernandez, et al.
British Journal of Haematology|March 14, 2012
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trialJonathan I Sive, Georgina Buck, Adele Fielding, et al.
European Journal of Haematology|October 26, 2011
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapyMichelle A Elliott, Louis Letendre, Ayalew Tefferi, et al.
Pageof 46